EGFR
EGFR (epidermal growth factor receptor) inhibitors are compounds that block the signaling of EGFR, a receptor that is often overexpressed in various cancers and plays a critical role in angiogenesis. EGFR inhibitors are used to prevent tumor growth and metastasis by disrupting the pathways that promote blood vessel formation in tumors. These inhibitors are widely used in cancer research and therapy. At CymitQuimica, we offer a diverse selection of high-quality EGFR inhibitors to support your research in oncology and angiogenesis.
Read more
YK-029A
CAS:2064269-82-3
YK-029A, an orally active EGFR mutant inhibitor, targets both EGFR T790M and EGFRex20ins mutations.
Formula:
C27H32N8O2
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
500.6
Ref: TM-T79461
| 25mg | 1,549.00 € | ||
| 50mg | 2,038.00 € | ||
| 100mg | 2,617.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
ALK/EGFR-IN-1
CAS:2730430-08-5
ALK/EGFR-IN-1 (Compound 8l) is a dual inhibitor targeting both ALK and EGFR, effectively blocking their …
Formula:
C27H34ClN7O3S
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
572.12
Ref: TM-T79392
| 25mg | 1,549.00 € | ||
| 50mg | 2,038.00 € | ||
| 100mg | 2,617.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
EGFR/CSC-IN-1
CAS:2820447-02-5
EGFR/CSC-IN-1 is a dual inhibitor targeting both the epidermal growth factor receptor (EGFR [IC50 10.52 …
Formula:
C54H54Cl2FN7O7S2
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
1067.08
Ref: TM-T73995
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 10 Feb 2025
HKI-357
CAS:848133-17-5
HKI-357 irreversibly inhibits EGFR/ERBB2 (IC50: 34/33 nM), blocks EGFR Y1068 autophosphorylation, and AKT/MAPK phosphorylation.
Formula:
C31H29ClFN5O3
Purity:
95.11%
Color and Shape:
Solid
Molecular weight:
574.05
Ref: TM-T11569
| 1mg | 78.00 € | ||
| 5mg | 149.00 € | ||
| 10mg | 222.00 € | ||
| 25mg | 452.00 € | ||
| 50mg | 647.00 € | ||
| 100mg | 920.00 € | ||
| 1mL*10mM (DMSO) | 186.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
Simotinib
CAS:944258-89-3
Simotinib (AL-6802) is an EGFR tyrosine kinase inhibitor (IC50 : 19.9 nM) with antitumour activity …
Formula:
C25H26ClFN4O4
Purity:
99.7%
Color and Shape:
Liquid
Molecular weight:
500.95
Ref: TM-T35916
| 1mg | 185.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
EGFR-IN-1
CAS:1625677-63-5
EGFR-IN-1: an oral, irreversible EGFR inhibitor targeting L858R/T790M mutations with high selectivity, showing potent antitumor …
Formula:
C28H30N6O4
Purity:
98%
Color and Shape:
Solid
Molecular weight:
514.58
Ref: TM-T11157
| 25mg | 1,688.00 € | ||
| 50mg | 2,225.00 € | ||
| 100mg | 2,897.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
JND3229
CAS:2260886-64-2
JND3229 inhibits EGFRC797S; IC50: 5.8-30.5 nM; halts cell growth; effective in non-small cell lung cancer …
Formula:
C33H41ClN8O2
Purity:
97.35%
Color and Shape:
Solid
Molecular weight:
617.18
Ref: TM-T15615
| 1mg | 60.00 € | ||
| 5mg | 126.00 € | ||
| 10mg | 186.00 € | ||
| 1mL*10mM (DMSO) | 167.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
PAT-505
CAS:1782070-22-7
PAT-505 is an autologous epidermal growth factor inhibitor.
Formula:
C23H18ClF2N3O2S
Purity:
98.84%
Color and Shape:
Solid
Molecular weight:
473.92
Ref: TM-T12372
| 1mg | 278.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
BGB-102
CAS:807640-87-5
BGB-102 (JNJ-26483327) is a kinase inhibitor targeting FLT3 and YES1 and an antagonist targeting EGFR …
Formula:
C22H25BrN4O2
Purity:
99.02%
Color and Shape:
Solid
Molecular weight:
457.36
Ref: TM-T10531
| 1mg | 305.00 € | ||
| 5mg | 759.00 € | ||
| 10mg | 1,002.00 € | ||
| 25mg | 1,512.00 € | ||
| 50mg | 2,032.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
BGB-8035
CAS:2283349-24-4
BGB-8035 is a BTK inhibitor with antitumor activity that inhibits BTK, TEC, and EGFR.BGB-8035 is …
Formula:
C24H31N5O4
Purity:
96.74%
Color and Shape:
Liquid
Molecular weight:
453.53
Ref: TM-T73381
| 1mg | 384.00 € | ||
| 5mg | 911.00 € | ||
| 10mg | 1,225.00 € | ||
| 25mg | 1,828.00 € | ||
| 50mg | 2,394.00 € | ||
| 100mg | 3,154.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
BEBT-109
CAS:2050906-40-4
BEBT-109 is a potent selective inhibitor of pan-mutant EGFR with enhanced pharmacokinetic properties, suitable for …
Formula:
C27H32N8O3
Purity:
99.01%
Color and Shape:
Liquid
Molecular weight:
516.59
Ref: TM-T80643
| 1mg | 187.00 € | ||
| 5mg | 462.00 € | ||
| 10mg | 662.00 € | ||
| 25mg | 1,033.00 € | ||
| 50mg | 1,425.00 € | ||
| 100mg | 1,885.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
EGFR-IN-85
CAS:1956378-29-2
EGFR-IN-85 (Compound 1), an EGFR inhibitor, exhibits potent activity with an IC50 of 0.19 μM …
Formula:
C26H30N8O2
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
486.57
Ref: TM-T78574
| 25mg | 1,410.00 € | ||
| 50mg | 1,851.00 € | ||
| 100mg | 2,337.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
EGFR-IN-61
CAS:2890261-81-9
EGFR-IN-61 inhibits EGFR kinase (IC50: 42 nM L858R/T790M, 137 nM L858R/T790M/C797S, 743 nM WT) and …
Formula:
C33H37ClN8O3
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
629.15
Ref: TM-T73128
| 25mg | 1,410.00 € | ||
| 50mg | 1,851.00 € | ||
| 100mg | 2,337.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
EGFR-IN-8
CAS:2407957-87-1
EGFR-IN-8, a dual inhibitor targeting both EGFR and c-Met, shows potential as a promising candidate …
Formula:
C32H23ClF3N7O4
Purity:
97.45%
Color and Shape:
Solid
Molecular weight:
662.02
Ref: TM-T11162
| 1mg | 74.00 € | ||
| 5mg | 166.00 € | ||
| 10mg | 266.00 € | ||
| 25mg | 440.00 € | ||
| 50mg | 602.00 € | ||
| 100mg | 825.00 € |
Estimated delivery in United States, on Monday 24 Feb 2025
BPI-15086
CAS:1644502-33-9
BPI-15086 is an orally active, effective, irreversible inhibitor selective for mutations, targeting both EGFR and …
Formula:
C29H33ClN8O4
Color and Shape:
Liquid
Molecular weight:
593.08
Ref: TM-T200004
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 10 Mar 2025
EGFR-IN-122
CAS:1807453-44-6
EGFR-IN-122 (compound Yfq07) serves as a potent inhibitor of EGFR. It effectively inhibits the proliferation …
Formula:
C19H20N4O3
Color and Shape:
Liquid
Molecular weight:
352.39
Ref: TM-T200157
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 10 Mar 2025
SST0116CL1
CAS:1799802-29-1
SST0116CL1 is an HSP90 inhibitor (IC50: 0.21 μM) that targets the ATP-binding pocket of Hsp90, …
Formula:
C22H31ClN4O6
Color and Shape:
Liquid
Molecular weight:
482.96
Ref: TM-T200022
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 10 Mar 2025
Tarloxotinib bromide
CAS:1636180-98-7
Tarloxotinib bromide (TH-4000) is an irreversible inhibitor of EGFR/HER2.
Formula:
C24H24Br2ClN9O3
Purity:
97.15%
Color and Shape:
Solid
Molecular weight:
681.77
Ref: TM-T13088
| 1mg | 136.00 € | ||
| 5mg | 272.00 € | ||
| 10mg | 416.00 € | ||
| 25mg | 681.00 € | ||
| 50mg | 902.00 € | ||
| 100mg | 1,261.00 € | ||
| 1mL*10mM (DMSO) | 420.00 € |
Estimated delivery in United States, on Monday 10 Mar 2025
Neptinib
CAS:2085843-51-0
Neptinib (NEP010), a derivative of Afatinib, exhibits enhanced antitumor properties and improved pharmacokinetics when administered …
Formula:
C22H23ClFN5O2
Color and Shape:
Liquid
Molecular weight:
443.9
Ref: TM-T89923
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 10 Mar 2025
ES-072
CAS:2089721-94-6
ES-072, a selective inhibitor targeting the EGFR mutant (EGFR-T790M), is administered orally. By hindering EGFR-T790M …
Formula:
C25H27F3N8O2
Color and Shape:
Liquid
Molecular weight:
528.53
Ref: TM-T200087
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 10 Mar 2025
